This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly those related to neurotransmitter regulation. Its structure, featuring a fluoro and methoxy substituent, allows for selective binding to specific receptors, making it valuable in the design of compounds with potential antidepressant or anxiolytic properties. Additionally, it is explored in research settings for its potential use in creating novel therapeutic agents for pain management and neurological conditions.